AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia

Cancer Research

Volumn 70, Issue 10, 2010, Pages 3985-3995

  Dunne, Jenny ^a   Gascoyne, Duncan M ^b   Lister, T Andrew ^a   Brady, Hugh J M ^b   Heidenreich, Olaf ^c   Young, Bryan D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AML1 ETO FUSION PROTEIN; BETA ACTIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYBRID PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR POU4F1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; AML1 GENE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BRN3A GENE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CHROMOSOME DUPLICATION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ETO GENE; GENE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POU4F1 GENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; UPREGULATION;

ADULT; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYONIC STEM CELLS; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, MYELOID, ACUTE; LIVER; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR BRN-3A; TRANSFECTION; TRANSLOCATION, GENETIC;

EID: 77952804016     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3604     Document Type: Article

References (45)

1. Schoch C, Kohlmann A, Schnittger S, et al. Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci U S A 2002;99: 10008-10013 (Pubitemid 34831163)
2. Debernardi S, Lillington DM, Chaplin T, et al. Genome-wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation-mediated fusion events. Genes Chromosomes Cancer 2003;37:149-158 (Pubitemid 36529782)
3. Ross ME, Mahfouz R, Onciu M, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004;104:3679-3687
4. Licht JD. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene 2001;20:5660-5679 (Pubitemid 32928105)
5. Peterson LF, Boyapati A, Ahn EY, et al. Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood 2007;110:799-805. (Pubitemid 47267414)
6. Rhoades KL, Hetherington CJ, Harakawa N, et al. Analysis of the role of AML1-ETO in leukemogenesis, using an Inducible transgenic mouse model. Blood 2000;96:2108-2115
7. Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MAS, Nimer SD. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 2002;99:15-23.
8. de Guzman CG, Warren AJ, Zhang Z, et al. Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation. Mol Cell Biol 2002; 22:5506-5517 (Pubitemid 34755760)
9. Tonks A, Tonks AJ, Pearn L, et al. Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal. Leukemia 2004;18:1238-1245 (Pubitemid 39023134)
10. Heidenreich O, Krauter J, Riehle H, et al. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood 2003;101:3157-3163 (Pubitemid 36858010)
11. Dunne J, Cullmann C, Ritter M, et al. siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8; 21)-positive cell lines and primary AML blasts. Oncogene 2006;25:6067-6078
12. Fazi F, Zardo G, Gelmetti V, et al. Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood 2007; 109:4432-4440 (Pubitemid 46743413)
13. Yergeau DA, Hetherington CJ, Wang Q, et al. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet 1997;15:303-306 (Pubitemid 27098728)
14. Fenske TS, Pengue G, Mathews V, et al. Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice. Proc Natl Acad Sci U S A 2004;101:15184-15189 (Pubitemid 39391739)
15. Wang YY, Zhou GB, Yin T, et al. AML1-ETO and C-KIT mutation/ overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci U S A 2005; 102:1104-1109 (Pubitemid 40170733)
16. Schessl C, Rawat VPS, Cusan M, et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 2005;115:2159-2168 (Pubitemid 41134157)
17. Yan M, Kanbe E, Peterson LF, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med 2006;12:945-949 (Pubitemid 44175147)
18. Linggi B, Muller-Tidow C, van de Locht L, et al. The t(8;21) fusion protein, AML1-ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med 2002;8:743-750 (Pubitemid 34778729)
19. Follows GA, Tagoh H, Lefevre P, Hodge D, Morgan GJ, Bonifer C. Epigenetic consequences of AML1-ETO action at the human c-FMS locus. EMBO J 2003;22:2798-2809 (Pubitemid 36712375)
20. Alcalay M, Meani N, Gelmetti V, et al. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clin Invest 2003;112:1751-1761 (Pubitemid 38063733)
21. Fliegauf M, Stock M, Berg T, Lubbert M. Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO. Oncogene 2004;23:9070-9081 (Pubitemid 40013074)
22. Mulloy JC, Jankovic V, Wunderlich M, et al. AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34(+) cells, allowing nerve growth factor-induced expansion. Proc Natl Acad Sci U S A 2005;102:4016-4021 (Pubitemid 40392508)
23. Tonks A, Pearn L, Musson M, et al. Transcriptional dysregulation mediated by RUNX1-1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia 2007;21:2495-2505 (Pubitemid 350148893)
24. Lakin ND, Morris PJ, Theil T, et al. Regulation of neurite outgrowth and Snap-25 gene-expression by the Brn-3A transcription factor. J Biol Chem 1995;270:15858-15863
25. McEvilly RJ, Erkman L, Luo L, Sawchenko PE, Ryan AF, Rosenfeld MG. Requirement for Brn-3.0 in differentiation and survival of sensory and motor neurons. Nature 1996;384:574-577 (Pubitemid 26415936)
26. Xiang MQ, Gan L, Zhou LJ, Klein WH, Nathans J. Targeted deletion of the mouse POU domain gene Brn-3a causes a selective loss of neurons in the brainstem and trigeminal ganglion, uncoordinated limb movement, and impaired suckling. Proc Natl Acad Sci U S A 1996;93:11950-11955 (Pubitemid 26347229)
27. Ensor E, Smith MD, Latchman DS. The BRN-3A transcription factor protects sensory but not sympathetic neurons from programmed cell death/apoptosis. J Biol Chem 2001;276:5204-5212 (Pubitemid 37371417)
28. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid-leukemia cell-line (Kasumi-1) with 8-21 chromosome-translocation. Blood 1991;77:2031-2036
29. Ruiz A, Williams O, Brady HJM. The Ikaros splice isoform, Ikaros 6, immortalizes murine haematopoietic progenitor cells. Int J Cancer 2008;123:1240-1245
30. Gascoyne DM, Long E, Veiga-Fernandes H, et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 2009;10:1118-U99.
31. Yan M, Ahn EY, Hiebert SW, Zhang DE. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood 2009;113:883-886
32. Hannon GJ, Sun PQ, Carnero A, et al. Molecular genetics - MaRX: an approach to genetics in mammalian cells. Science 1999;283: 1129-1130
33. Fedtsova NG, Turner EE. Brn-3.0 expression identifies early postmitotic CNS neurons and sensory neural precursors. Mech Dev 1995; 53:291-304.
34. Ivins S, Pemberton K, Guidez F, Howell L, Krumlauf R, Zelent A. Regulation of Hoxb2 by APL-associated PLZF protein. Oncogene 2003; 22:3685-3697 (Pubitemid 36760731)
35. Cartharius K, Frech K, Grote K, et al. Matlnspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005;21:2933-2942 (Pubitemid 40916416)
36. Trieu M, Ma A, Eng SR, Fedtsova N, Turner EE. Direct autoregulation and gene dosage compensation by POU-domain transcription factor Brn3a. Development 2003;130:111-121 (Pubitemid 36113948)
37. Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003; 17:2298-2307
38. Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocptic leukemia zinc finger protein. Blood 2000;96:3939-3947
39. Salat D, Liefke R, Wiedenmann J, Borggrefe T, Oswald F. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jκ/ SHARP-mediated repression of Notch target genes. Mol Cell Biol 2008;28:3502-3512 (Pubitemid 351657111)
40. Smith ML, Arch R, Smith LL, et al. Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3. Br J Haematol 2005;128: 318-323 (Pubitemid 40216153)
41. Gascoyne DM, Thomas GR, Latchman DS. The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1. Oncogene 2004;23: 3830-3840
42. Theil T, Mcleanhunter S, Zornig M, Moroy T. Mouse Brn-3 family of POU transcription factors - a new aminoterminal domain is crucial for the oncogenic activity of Brn-3A. Nucleic Acids Res 1993;21: 5921-5929 (Pubitemid 24023708)
43. Wiggins AK, Wei GW, Doxakis E, et al. Interaction of Brn3a and HIPK2 mediates transcriptional repression of sensory neuron survival. J Cell Biol 2004;167:257-267 (Pubitemid 39435069)
44. Li XL, Arai Y, Harada H, et al. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1-and p53-mediated transcription. Oncogene 2007;26:7231-7239 (Pubitemid 350085316)
45. Ma L, Lei L, Eng R, Turner E, Parada LF. Brn3a regulation of TrkA/ NGF receptor expression in developing sensory neurons. Development 2003;130:3525-3534 (Pubitemid 37010015)